Phospho-PKC (pan) (βII Ser660) Antibody

Skip to product information
1 of 1

Selleck Chemicals

SKU:F3551-20UL

Regular price €139,00 EUR
Regular price Sale price €139,00 EUR
Sale Sold out
Taxes included. Shipping calculated at checkout.
Size
Quantity
View full details

About the Target

Phospho-PKC (pan) (βII Ser660) is a target of interest in many antibody-based workflows. Phospho-PKCβII (Ser660) refers to phosphorylation at the hydrophobic motif site in the C-terminal tail of the conventional protein kinase C beta II isoform, part of the AGC family of serine/threonine kinases. PKCβII comprises a regulatory domain and a catalytic domain, with Ser660 located in the hydrophobic motif of the C-tail. Depending on the literature source, Phospho-PKC (pan) (βII Ser660) may also be discussed as Phospho-PKC (pan) (betaII Ser660) and PRKCA/PRKCB/PRKCD/PRKCE/PRKCH/PRKCQ; Phospho-PKC (pan) (betaII Ser660).

Reported cellular context includes cell membrane, cytoplasm, membrane, and mitochondrion, which can matter when signal is compared across treatments or changing cell states. Following Phospho-PKC (pan) (βII Ser660) across matched perturbations can help separate abundance effects from shifts in localization, complex assembly, or pathway state. In practice, this target is often considered at the family or isoform-group level, so experimental interpretation benefits from matched controls and clear comparison logic.

Research Context

Phospho-PKC (pan) (βII Ser660) is commonly interpreted in the context of cell signaling research, and readouts are often stronger when a study separates expression changes from compartment-level redistribution. When reported signal spans cell membrane, cytoplasm, and membrane, a defined reference condition can make comparisons more interpretable across perturbations, passages, or replicate sets.

Consider these angles when interpreting target-level changes:

  • apparent redistribution between cell membrane, cytoplasm, and membrane across matched conditions
  • signal-dependent shifts after ligand, inhibitor, or growth-factor perturbation
  • differences between total target abundance and site-specific regulation when modified forms are compared
  • co-patterning with orthogonal markers and control conditions that clarify pathway state

Variant Considerations

If your project spans exploratory questions, the regular version offers a balanced option for establishing baseline signal behavior for Phospho-PKC (pan) (βII Ser660). This can help when protocols evolve over time and the goal is to compare experiments using a stable reference workflow.

Standardize sampling time, control choice, and downstream analysis thresholds so apparent differences in Phospho-PKC (pan) (βII Ser660) reflect biology rather than handling. When interpreting Phospho-PKC (pan) (βII Ser660), it is often useful to decide early whether the main question is overall abundance, compartmental enrichment, or context-dependent redistribution.

For multi-run studies, a shared reference condition can keep Phospho-PKC (pan) (βII Ser660) trends easier to compare across datasets. That kind of consistency is especially helpful when follow-up work expands to new perturbations, model systems, or longitudinal collections.

Targets:
PRKCA • PRKCB • PRKCD • PRKCE • PRKCH • PRKCQ • PRKCZ
Research Area:
Cell Signaling
Application:
ELISA • IHC • WB
Reactivity:
Human • Mouse • Rat
Specificity:
Phospho-PKC (pan) (βII Ser660) Antibody [G6B3] recognizes endogenous levels of multiple PKC isoforms (pan), including PKCβII, only when phosphorylated at Ser660.
Host:
Rabbit
Clonality:
Monoclonal
Clone:
G6B3
UniProt:
P17252P05771Q05655Q02156P24723Q04759
Storage Buffer:
PBS, pH 7.2+50% Glycerol+0.05% BSA+0.01% NaN₃
Storage Temperature:
-20°C

For Research Use Only. Not intended for diagnostic or therapeutic use.
Products may be subject to intellectual property rights.

The purchase of this product does not grant any license for commercial use, manufacturing, or clinical applications. The user is responsible for ensuring compliance with applicable laws and third-party rights.